ReviewFrontiers in immunology2025

Effectiveness and safety of rituximab monotherapy versus conventional regimens for adult idiopathic membranous nephropathy: real-world retrospective study.

Jing Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.